HomeAI · summaries
Storia in 3 fonti
Natco Pharma Q1 net, revenue slump on lower cancer drug sales
Natco Pharma's Q1 profit plummets 57% due to declining Lenalidomide sales, resulting in a significant revenue drop.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Natco Pharma Q1 profit falls 57 pc to Rs 206.5 cr
Natco Pharma has reported a stark profit decline in the first quarter, largely driven by reduced sales of its leading cancer drug, lenalidomide. This led to a pronounced drop in…
- ·
thehindubusinessline.com
Natco Pharma’s Q1 net down 57% at ₹206 crore; to raise ₹2,000 crore
Revenue stood at ₹794 crore marking a decline of 43% in the quarter under review as against ₹1,390 crore for the corresponding quarter last year.
